Disclosures for "A Pathogenic Heterozygous Mutation Affecting ATP13A2 in Parkinson's Disease "
-
Dr. Thomsen has nothing to disclose.
-
Dr. Malfer has nothing to disclose.
-
Zhiyv Niu has nothing to disclose.
-
Dr. Ross has nothing to disclose.
-
Miss Santoro has nothing to disclose.
-
The institution of Dr. Savica has received research support from ACADIA Pharmaceuticals, Inc.